期刊文献+

巨球蛋白血症3例及文献复习 被引量:2

Waldenstrom macroglobulinemia:three cases report and literature review
暂未订购
导出
摘要 目的:探讨巨球蛋白血症的临床表现、诊断、鉴别诊断和治疗。方法:分析我科收治的3例巨球蛋白血症患者的临床资料及诊治过程,并复习相关文献。结果:本文3例患者发病时均出现不同程度贫血、单克隆IgM及骨髓浆细胞样淋巴细胞浸润,例1及例3可见高黏滞综合征所致鼻出血或牙龈出血。其中例1及例2接受苯丁酸氮芥联合强的松方案治疗,例3未接受治疗。例1目前病情平稳,例2死亡,例3失访。结论:巨球蛋白血症的诊断与鉴别诊断有赖于形态学及免疫表型检查。烷化剂、嘌呤类似物及利妥昔单抗是WM一线治疗药物。 Objective:To investigate the clinical manifestations,diagnosis,differential diagnosis and therapy of Waldenstrom macroglobulinemia.Methods:We reported three cases of Waldenstrom macroglobulinemia.Its clinical data,diagnosis and treatment were studied and the literatures were reviewd.Results:Anemia,monoclonal IgM protein and bone marrow are infiltrated with lymphoplasmacytic cells were occued on the cases we reported.Nasal bleeding or bleeding gums caused by hyperviscosity syndrome occurred on Ex1 and ex3.Ex1 and ex2 were treated with chlorambucil and prednisone,ex3 refused,ex1 is in stable condition at present,ex2 died,ex3 lost to follow.Conclusion:The diagnosis and differential diagnosis of Waldenstrom macroglobulinemia depends on morphology and immunophenotyping.Alkylating agent,purine and rituximab is its fiest-line therapy.
出处 《现代肿瘤医学》 CAS 2013年第6期1325-1327,共3页 Journal of Modern Oncology
基金 辽宁中医药大学附属医院青年基金资助项目(编号:200906)
关键词 巨球蛋白血症 多发性骨髓瘤 慢性淋巴细胞白血病 IGM waldenstrom macroglobulinemia multiple myeloma chronic lymphocytic leukemia IgM
  • 相关文献

参考文献31

  • 1Owen RG,Treon SP,A1 - Katib A,et al. Clinicopathological defini-tion of Waldenstrom macroglobulinemia : consensus panel recom-menddation from the Second International Workshop on Walden-strom^ macroglobulinemia [ J ] ? Semin Oncol,2003 ,30 (2) : 110 -115.
  • 2Herrinton LJ, Weiss NS. Incidence of Waldenstrom"s macroglobu-linemia [J]. Blood, 1993,82: 3148 -3150.
  • 3Groves FD,Travis LB,Devesa SS,et al. Waldenstrom^ macroglobu-linemia:incidence patterns in the United States, 1988 - 1994[J].Cancer, 1998,82(6) :1078 - 1081.
  • 4Wang H,Chen Y,Li F,et al. Temporal and geographic variations ofWaldenstrom macroglobulinemia incidence : a large population -based study[ J]. Cancer,2012,118(15) :3793 -3800.
  • 5Sekhar J,Sanfilippo K,Zhang Q, et al. Waldenstrom macroglobu-linemia: a surveillance epidemiology, and end results database re-view from 1988 to 2005[ J]. Leuk Lymphoma,2012,53 (8) : 1625-1626.
  • 6Ansell SM,Kyle RA,Reeder CB,et al. Diagnosis and managementof Waldenstrom macroglobulinemia : Mayo stratification of macro-globulinemia and risk - adapted therapy ( mSMART) guidelines[J]. Mayo Clin Proc,2010,85(9) :824 -833.
  • 7Kyle RA,Rajkumar SV. Criteria for diagnosis,staging,risk stratifi-cation and response assessment of multiple myeloma[ J]. Leukemi-a,2009,23( 1) :3 -9.
  • 8Swerdlow SH, Campo E, Harris NL,et al. WHO classification oftumours of haematopoietic and lymphoid tissues [ M ]. Geneva,Switzerland : International Agency for Research on Cancer( IARC),2008:441.
  • 9Gertz MA. Waldenstrom macroglobulinemia[ J] ? Hematology,2012,17(SuppllO):S112-116.
  • 10Bjorkholm M, Johansson E,Papamichael D,et al. Patterns of clini-cal presentation, treatment, and outcome in patients with Walden-strom -s macroglobulinemia : a two - institution study [ J ]. SeminOncol,2003 ,30(2) :226 -230.

共引文献171

同被引文献28

  • 1蒋道怡,王红,郭建军.主要表现为贫血的原发性巨球蛋白血症[J].临床误诊误治,2005,18(9):636-636. 被引量:2
  • 2Owen R G, Treon S P, A1 Katib A, et al. Clinicopatho- logical definition of Waldenstrom "s macroglobulinemia: consensus panel recommendations from the Second Inter- national Workshop on Waldenstrom "s Macroglobulinemia [J]. Semin Oncol, 2003,30(2) :110-115.
  • 3Treon S P, Hunter Z R, Aggarwal A, et al. Characteriza- tion of familial Waldenstroms macroglobulinemia[ J]. Ann Oncol, 2006,17 ( 3 ) :488-494.
  • 4Ansell S M, Kyle R A, Reeder C B, et al. Diagnosis and management of Waldenstrom macroglobulinemia: Mayo stratification of macroglobulinemia and risk-adapted thera- py (mSMART) guidelines[ J]. Mayo Clin Proc, 2010,85 (9) :824-833.
  • 5Gertz M A, Merhni G, Treon S P. Amyloidosis and Wal- denstrom "s macroglobulinemia [ J ]. Hematology ( Am Soc Hematol Educ Program) , 2004:257-282.
  • 6Gertz M A. Waldenstrom macroglobulinemia [ J]. Hema- tology, 2012,17 ( Suppl 1 ) : 112-116.
  • 7Sekhar J, Sanfilippo K, Zhang Q, et al. Waldenstrom macroglobulinemia: a Surveillance, Epidemiology, and End Results database review from 1988 to 2005 [ J]. Leuk Lymphoma, 2012,53 ( 8 ) : 1625-1626.
  • 8Gertz M A. Waldenstrom macroglobulinemia: 2013 up- date on diagnosis, risk stratification, and management [J]. Am J Hematol, 2013,88(8) :703-711.
  • 9Graziani M, Merlini G, Petrini C. Guidelines for the a- nalysis of Bence Jones protein [ J ]. Clin Chem Lab Med, 2003,41 ( 3 ) :338-346.
  • 10International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies, multiple mye- loma and related disorders: a report of the International Myeloma Working Group [ J]. Br J Haematol, 2003,121 (5) :749-757.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部